<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303926/" ref="ordinalpos=4021&amp;ncbi_uid=7121531&amp;link_uid=PMC4303926" image-link="/pmc/articles/PMC4303926/figure/f1/" class="imagepopup">Figure 1. Activation of SHH <span class="highlight" style="background-color:">signaling</span> shortens QT interval in healthy animals..  From: Activation of Sonic hedgehog <span class="highlight" style="background-color:">signaling</span> in ventricular cardiomyocytes exerts cardioprotection against ischemia reperfusion injuries. </a></div><br /><div class="p4l_captionBody">(A) ECGs were acquired over 6 hours after different treatments (i.p.-injected), in control animals. Representative ECGs recorded in control, N-SHH- and MPsSHH+-treated animals indicate a shortening of QT interval after SHH signaling pathway activation. (B) Mean QTc values recorded before (t = 0, left column) and 6 hours after injection (t = 6, right column) of the vehicle (control, n = 5), N-SHH (n = 8), N-SHH+Hexamethonium (N-SHH+Hex, n = 6), MPsSHH+ (n = 7), N-SHH and cyclopamine (N-SHH+Ccl, n = 6) and cyclopamine alone (Control + Ccl, n = 6). (* p &lt; 0.05, QTc at 6 h vs t = 0).</div></div>